Arrowhead Pharmaceuticals
ARWR
#2176
Rank
NZ$14.70 B
Marketcap
NZ$106.35
Share price
-4.98%
Change (1 day)
163.01%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): -NZ$85.32 Million

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.57 Billion. In 2024 the company made an earning of -NZ$1.04 Billion a decrease over its 2023 earnings that were of -NZ$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$85.32 Million-91.79%
2024 -NZ$1.04 Billion112.45%
2023 -NZ$0.49 Billion87.79%
2022 -NZ$0.27 Billion-20.1%
2021 -NZ$0.33 Billion67.59%
2020 -NZ$0.2 Billion-347.53%
2019 NZ$78.57 M-245.59%
2018 -NZ$53.97 Million-13.17%
2017 -NZ$62.16 Million-52.28%
2016 -NZ$0.14 Billion-16.57%
2015 -NZ$0.16 Billion30.32%
2014 -NZ$0.12 Billion171.62%
2013 -NZ$44.11 Million16.56%
2012 -NZ$37.84 Million107.53%
2011 -NZ$18.24 Million
2008 -NZ$64.23 Million-8.07%
2007 -NZ$69.87 Million70.37%
2006 -NZ$41.01 Million122.51%
2005 -NZ$18.43 Million147.41%
2004 -NZ$7.45 Million2002.28%
2003 -NZ$0.36 Million-85.61%
2002 -NZ$2.47 Million1371.97%
2001 -NZ$0.17 Million-13.45%
2000 -NZ$0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alnylam Pharmaceuticals
ALNY
NZ$0.22 B-273.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion 56.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-188.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-NZ$0.19 Billion 43.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-43,253.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.45 Billion 4,089.31%๐Ÿ‡บ๐Ÿ‡ธ USA